Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 9 EP applications Miriam Elizabeth Morris has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12807562

IBUPROFEN CHEWABLE TABLET

IPC classification:
A61K 9/20, A61K 31/192, A61P 29/00
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12782731

SUSTAINED RELEASE PARACETAMOL FORMULATIONS

IPC classification:
A61K 9/20, A61K 9/22, A61K 9/24, A61K 31/167, A61P 9/02
Applicant:
GlaxoSmithKline LLC
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13720869

NOVEL COMPOUNDS

IPC classification:
A61P 11/06, A61P 17/06, C07D 213/76, C07D 405/12, C07D 405/14, C07D 413/12, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Agent:
GlaxoSmithKline Intellectual Property Management Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline Intellectual Property Limited
Status:
GRANT OF PATENT INTENDED
EP14766225

NOVEL SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND THEIR USE

IPC classification:
A61K 31/4439, A61K 31/444, A61P 27/00, C07D 401/04, C07D 401/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14771907

DENTIFRICE COMPOSITION COMPRISING SINTERED HYDROXYAPATITE

IPC classification:
A61K 8/24, A61Q 11/00
Applicant:
Glaxo Group Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14815332

DENTIFRICE COMPOSITION COMPRISING SPHERICAL FUSED ALUMINIUM OXIDE PARTICLES

IPC classification:
A61K 8/02, A61K 8/26, A61Q 11/00
Applicant:
Glaxo Group Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15726738

PREPARATION AND USE OF CRYSTALLINE BETA-D-NICOTINAMIDE RIBOSIDE

IPC classification:
A61K 31/706, A61P 3/00, A61P 21/00, A61P 31/10, A61P 43/00, C07H 1/00, C07H 19/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15729244

NICOTINAMIDE RIBOSIDE ANALOGS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/7064, A61P 3/10, A61P 17/00, A61Q 17/00, C07H 19/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15842532

NOVEL FORMULATIONS

IPC classification:
A61K 31/74
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature